Lower Limb Revascularization for PAD Using a Heparin-Coated PTFE Conduit
- 28 March 2011
- journal article
- Published by SAGE Publications in Vascular and Endovascular Surgery
- Vol. 45 (4) , 329-334
Abstract
Objective: To assess the patency of the PROPATEN Graft in lower extremity bypasses. Methods: We retrospectively reviewed all lower extremity bypasses with the PROPATEN Graft from 2007-2009 at a single institution. There were 68 implants—56% male; mean age 69. Comorbidities included hypertension (HTN; 81%), hyperlipidemia (72%), coronary artery disease (CAD; 74%), and smoking (59%). Most patients were Rutherford category 4 or higher. A total of 34% of patients had only 1 runoff vessel; 10% of patients required a complex concomitant procedure with sequential extremity revascularization. Statistics were via Kaplan Meier. Results: Mean follow-up was10.4 ± 8.0 months (0-30). Patency was excellent in all positions. Primary patency for all patients was 94.0% and 86.0% at 30 days and 18 months, respectively. Limb salvage at 30 days was 95%, and at 18 months was 90%. No patients developed HIT. Ten patients lost graft patency. These patients had severe Peripheral Vascular Disease (PVD), with rest pain or tissue loss, poor runoff (no runoff or single vessel runoff), compromised inflow, and restored competitive flow. Fifty percent of the failed grafts were in the infrapopliteal position. Endovascular intervention and graft thrombectomy to restore patency was attempted in 2 patients and was unsuccessful. Conclusion: The GORE PROPATEN Vascular Graft demonstrates excellent patency in all arterial positions and may be the conduit of choice for all prosthetic bypasses.Keywords
This publication has 22 references indexed in Scilit:
- Heparin-bonded Dacron or polytetrafluorethylene for femoropopliteal bypass: Five-year results of a prospective randomized multicenter clinical trialJournal of Vascular Surgery, 2004
- Small-caliber heparin-coated ePTFE grafts reduce platelet deposition and neointimal hyperplasia in a baboon modelJournal of Vascular Surgery, 2004
- Evaluation of platelet deposition and neointimal hyperplasia of heparin-coated small-caliber ePTFE grafts in a canine femoral artery bypass model1Journal of Surgical Research, 2004
- Silyl-heparin bonding improves the patency and in vivo thromboresistance of carbon-coated polytetrafluoroethylene vascular graftsJournal of Vascular Surgery, 2004
- Saphenous Vein Versus PTFE for Above-Knee Femoropopliteal Bypass. A Review of the LiteratureEuropean Journal of Vascular and Endovascular Surgery, 2004
- Improvements in GORE-TEX® vascular graft performance by Carmeda® bioactive surface heparin immobilizationEuropean Journal of Vascular and Endovascular Surgery, 2003
- Long-term results of femorotibial bypass with vein or polytetrafluoroethyleneBritish Journal of Surgery, 1998
- Randomized trial comparing infrainguinal polytetrafluoroethylene bypass grafting with and without vein interposition cuff at the distal anastomosisJournal of Vascular Surgery, 1997
- PTFE or HUV for femoro-popliteal bypass: A multi-centre trialEuropean Journal of Vascular Surgery, 1991
- Present status of reversed vein bypass grafting: Five-year results of a modern seriesJournal of Vascular Surgery, 1990